Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 25Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 16Prostatic Neoplasms 15Lymphoma, B-Cell 15Stomach Neoplasms 13Carcinoma, Hepatocellular 12Recurrence 11Pancreatic Neoplasms 11Lung Neoplasms 11Leukemia, Myeloid, Acute 11Carcinoma, Non-Small-Cell Lung 11Burkitt Lymphoma 11Solid Tumor 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Glioma 7Sarcoma 6Polycystic Ovary Syndrome 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Interventions

Deamino Arginine Vasopressin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Castrate Resistance Prostate Cancer × Clear all
NCT04113005 2019-10-02

Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer

Sunnybrook Health Sciences Centre

Phase EARLY_PHASE1 Unknown
10 enrolled
Genitourinary

Castrate Resistance Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡